ABC Pharmaceuticals – FDA Inspection, Feb 27, 2025

Record Details

This FDA Inspection record concerns ABC Pharmaceuticals, with an inspection on February 27, 2025, issued by the San Francisco District Office, covering human drugs.

Company: ABC Pharmaceuticals
Inspection Date: February 27, 2025
Product Type: Human Drugs
Office: San Francisco District Office
People: Linda Thai (FDA Associated Person)
Philip F. Istafanos (Issuing Officer)

View Company Profile

ID · 085bae28-49b0-42f7-a07f-cde85dda7f25

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1262486
FDA center: Human Drugs
Project area: Drug Quality Assurance
Outcome: Form 483 issued, view the record

FDA Citations

21 CFR 211.160(b)Scientifically sound laboratory controls

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore ABC Pharmaceuticals

FDA Inspection

ABC PharmaceuticalsFebruary 27, 2025